Glofit-GemOx: a new treatment paradigm in relapsed or refractory diffuse large B-cell lymphoma?

被引：0
|
作者：
Sureda, Anna [1 ]
Pavlosky, Astrid [2 ,3 ]
机构：
[1] Univ Barcelona, Inst Catala Oncol LHosp, Clin Haematol Dept, IDIBELL, Barcelona 08908, Spain
[2] Pavlovsky Ctr, Buenos Aires, Argentina
[3] Fundaleu, Haematol Dept, Buenos Aires, Argentina
来源：
LANCET | 2024年 / 404卷 / 10466期
关键词：
D O I：
10.1016/S0140-6736(24)02138-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1899 / 1901
页数：3
相关论文
共 50 条
  • [1] Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Friedberg, Jonathan W.
    HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 498 - 505
  • [2] Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma
    Salles, Gilles
    Dlugosz-Danecka, Monika
    Ghesquieres, Herve
    Jurczak, Wojciech
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 455 - 463
  • [3] Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma: New Approved Options
    Garcia-Sancho, Alejandro Martin
    Cabero, Almudena
    Gutierrez, Norma C.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [4] New and emerging therapies for the treatment of relapsed/refractory diffuse large B-cell lymphoma
    Moore, Donald C.
    Peery, Matthew R.
    Tobon, Katherine A.
    Raheem, Farah
    Hwang, Grace S.
    Alhennawi, Lin
    Hughes, Mitchell E.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1848 - 1858
  • [5] NEW TREATMENT FOR RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2021, 121 (06) : 21 - 22
  • [6] Primary Results of Patient-Reported Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Glofitamab Plus Gemcitabine and Oxaliplatin (Glofit-GemOx) Versus Rituximab Plus GemOx (R-GemOx) from the Phase III Starglo Study
    Gregory, Gareth P.
    Abramson, Jeremy S.
    Huang, Hui-Qiang
    Zhang, Qing-Yuan
    Ku, Matthew
    Yoon, Dok Hyun
    Fox, Christopher P.
    Abdulhaq, Haifaa
    Townsend, William
    Ashby, Joan
    Harris, Alana
    Orellana-Noia, Victor
    Simko, Stephen
    Kallemeijn, Martine
    Ta, Richard
    Relf, James
    Huang, Huang
    Lundberg, Linda
    Zhang, Huilai
    BLOOD, 2024, 144 : 5132 - 5133
  • [7] Loncastuximab Tesirine in the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Juarez-Salcedo, Luis Miguel
    Nimkar, Santosh
    Corazon, Ana Maria
    Dalia, Samir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
  • [8] Tafasitamab for refractory/relapsed diffuse large B-cell lymphoma
    Lu, Q.
    Huang, H.
    Tang, S.
    Wang, Y.
    Yang, D-H
    DRUGS OF TODAY, 2021, 57 (09) : 571 - 580
  • [9] Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Dickinson, Michael J.
    Carlo-Stella, Carmelo
    Morschhauser, Franck
    Bachy, Emmanuel
    Corradini, Paolo
    Iacoboni, Gloria
    Khan, Cyrus
    Wrobel, Tomasz
    Offner, Fritz
    Wu, Shang-Ju
    Cartron, Guillaume
    Hertzberg, Mark
    Sureda, Anna
    Perez-Callejo, David
    Lundberg, Linda
    Relf, James
    Dixon, Mark
    Clark, Emma
    Humphrey, Kathryn
    Hutchings, Martin
    Trney, Marek
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (24): : 2220 - 2231
  • [10] Developing New Strategies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Barca, Eva Gonzalez
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (23)
12345